Obstructive Sleep Apnea: Diagnosis and Severity
Obstructive sleep apnea (OSA) is repetitive upper airway collapse during sleep, causing apneas (≥10 sec cessation), hypopneas (≥30% flow reduction + arousal or desaturation), and arousals.
Diagnosis: polysomnography (PSG) is the gold standard. Home sleep apnea testing (HSAT) acceptable for uncomplicated moderate-to-severe OSA suspicion.
Apnea-Hypopnea Index (AHI) = apneas + hypopneas per hour: - Normal: <5/hr - Mild OSA: 5–14/hr - Moderate OSA: 15–29/hr - Severe OSA: ≥30/hr
Symptoms: loud snoring, witnessed apneas, gasping/choking, EDS (excessive daytime sleepiness), morning headaches, nocturia. STOP-BANG: screening questionnaire (≥3 = high risk).
Complications: hypertension, cardiovascular disease, arrhythmias (AFib), stroke, type 2 diabetes, metabolic syndrome, pulmonary hypertension.
- AHI: mild 5–14, moderate 15–29, severe ≥30 events/hr
- Gold standard diagnosis: overnight polysomnography (PSG)
- HSAT acceptable for uncomplicated moderate–severe OSA screening
- OSA complications: HTN, AFib, stroke, pulmonary hypertension, metabolic syndrome
- STOP-BANG: ≥3 positive answers = high risk for OSA
OSA is the most common sleep disorder in adults and the most common indication for CPAP therapy. Undiagnosed OSA is associated with a 2–3x increased risk of motor vehicle accidents.